V
Market Data
$0.59−$0.14 (−19.85%)
VTGN · Last trade
Prev Close
$0.73
Range (30d)
$0.59 – $0.74
Recent Filings
- 8-K7.8 MBVistagen Therapeutics, Inc.Jan 9, 5:26 PM ET·0001628280-26-001690
- 8-K135.1 KBVistagen Therapeutics, Inc.Dec 22, 5:29 PM ET·0001628280-25-058594
- 8-K299.7 KBVistagen Therapeutics, Inc.Dec 3, 4:47 PM ET·0001628280-25-055083
- 10-Q5.1 MBVistagen Therapeutics, Inc.Nov 13, 4:35 PM ET·0001628280-25-052079
- 8-K253.9 KBVistagen Therapeutics, Inc.Nov 13, 4:34 PM ET·0001628280-25-052077
- 8-K180.0 KBVistagen Therapeutics, Inc.Nov 4, 4:10 PM ET·0001628280-25-048827
- 8-K255.0 KBVistagen Therapeutics, Inc.Oct 29, 5:24 PM ET·0001628280-25-047188
- 8-K161.9 KBVistagen Therapeutics, Inc.Sep 15, 4:50 PM ET·0001411685-25-000081
- 10-Q4.8 MBVistagen Therapeutics, Inc.Aug 7, 4:57 PM ET·0001411685-25-000064
- 8-K8.7 MBVistagen Therapeutics, Inc.Aug 7, 4:56 PM ET·0001411685-25-000062
Insiders
10- Adler Reid G.Chief Legal Officer
- Anderson Cynthia LynnCHIEF FINANCIAL OFFICER
- Bonfiglio Gregory A.Director
- Cato Allen Easley10% Owner
- Commodore Capital LP10% Owner
- Cote Elissa S.Chief Corp Development Officer
- Cunningham Ann MichelleDirector
- Curley JoanneDirector
- DOTSON JERROLD DUANEACTING CFO
- Edick Paul RDirector
Tickers
Addresses
business
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA, 94080
mailing
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- Excaliber Enterprises, Ltd.2011-06-08